SCHEMBL1004083

SCHEMBL1004083

CNC(=O)c1cc(OC)c(C)c(OC)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 3/20 0.68
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
ALDH1A1 P00352 3/20 0.62
HPGD P15428 1/20 0.62
PLK1 P53350 2/20 0.55
LMNA P02545 3/20 0.50
HPGDS O60760 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALOX12 P18054 1/20 0.44
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
MAPK1 P28482 2/20 0.42
ALOX15 P16050 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9903880 0.84 PKM (0.62) RXFP1MEN1KMT2AALDH1A1HPGD
SCHEMBL4143482 0.84 ALDH1A1 (0.77) MEN1KMT2AALDH1A1HPGDPLK1
SCHEMBL31650388 0.82 ALDH1A1 (0.60) RXFP1MEN1KMT2AALDH1A1HPGD
SCHEMBL11855075 0.79 ALDH1A1 (0.57) RXFP1MEN1KMT2AALDH1A1HPGD
SCHEMBL9103250 0.79 TAS1R3 (0.56) MEN1KMT2AALDH1A1HPGDPLK1
SCHEMBL2114318 0.79 KMT2A (0.61) RXFP1MEN1KMT2AALDH1A1LMNA
SCHEMBL4151619 0.78 CYP1A2 (0.66) MEN1KMT2AALDH1A1HPGDPLK1
SCHEMBL21690111 0.78 ALDH1A1 (0.69) MEN1KMT2AALDH1A1HPGDPLK1
SCHEMBL16450577 0.78 ALDH1A1 (0.55) RXFP1MEN1KMT2AALDH1A1HPGD
SCHEMBL668540 0.77 CA12 (0.69) RXFP1MEN1KMT2ALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778219-B2 Ionic liquids for separation of olefin-paraffin mixtures UT-BATTELLE, LLC (US) 2014-07-15 US disclosed
US-20130338389-A1 IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES UT-BATTELLE, LLC (US) 2013-12-19 US disclosed
US-8535560-B2 Ionic liquids for separation of olefin-paraffin mixtures UT-BATTELLE, LLC (US) 2013-09-17 US disclosed
US-20110015461-A1 Ionic Liquids for Separation of Olefin-Paraffin Mixtures UT-BATTELLE, LLC (US) 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130338389-A1 IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES POU2F1, POU2F2, POF1B RXFP1 4072/4885MEN1 1717/4885KMT2A 3578/4885
US-20110015461-A1 Ionic Liquids for Separation of Olefin-Paraffin Mixtures POU2F1, POU2F2, POF1B RXFP1 4072/4885MEN1 1717/4885KMT2A 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.